Re-evaluation of the action potential upstroke velocity as a measure of the Na+ current in cardiac myocytes at physiological conditions
- PMID: 21217835
- PMCID: PMC3013114
- DOI: 10.1371/journal.pone.0015772
Re-evaluation of the action potential upstroke velocity as a measure of the Na+ current in cardiac myocytes at physiological conditions
Abstract
Background: The SCN5A encoded sodium current (I(Na)) generates the action potential (AP) upstroke and is a major determinant of AP characteristics and AP propagation in cardiac myocytes. Unfortunately, in cardiac myocytes, investigation of kinetic properties of I(Na) with near-physiological ion concentrations and temperature is technically challenging due to the large amplitude and rapidly activating nature of I(Na), which may seriously hamper the quality of voltage control over the membrane. We hypothesized that the alternating voltage clamp-current clamp (VC/CC) technique might provide an alternative to traditional voltage clamp (VC) technique for the determination of I(Na) properties under physiological conditions.
Principal findings: We studied I(Na) under close-to-physiological conditions by VC technique in SCN5A cDNA-transfected HEK cells or by alternating VC/CC technique in both SCN5A cDNA-transfected HEK cells and rabbit left ventricular myocytes. In these experiments, peak I(Na) during a depolarizing VC step or maximal upstroke velocity, dV/dt(max), during VC/CC served as an indicator of available I(Na). In HEK cells, biophysical properties of I(Na), including current density, voltage dependent (in)activation, development of inactivation, and recovery from inactivation, were highly similar in VC and VC/CC experiments. As an application of the VC/CC technique we studied I(Na) in left ventricular myocytes isolated from control or failing rabbit hearts.
Conclusions: Our results demonstrate that the alternating VC/CC technique is a valuable experimental tool for I(Na) measurements under close-to-physiological conditions in cardiac myocytes.
Conflict of interest statement
Figures
References
-
- Cascio WE. Myocardial ischemia: what factors determine arrhythmogenesis? J Cardiovasc Electrophysiol. 2001;12:726–729. doi: 10.1046/j.1540-8167.2001.00726.x. - DOI - PubMed
-
- Kléber AG, Fast V. Molecular and cellular aspects of re-entrant arrhythmias. Basic Res Cardiol 92. 1997;(Suppl 1):111–119. doi: 10.1007/BF00794075. - DOI - PubMed
-
- Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res. 2004;95:754–763. doi: 10.1161/01.RES.0000145047.14691.db. - DOI - PubMed
-
- Fozzard HA, Lee PJ, Lipkind GM. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr Pharm Des. 2005;11:2671–2686. doi: 10.2174/1381612054546833. - DOI - PubMed
-
- Postema PG, Wolpert C, Amin AS, Probst V, Borggrefe M, et al. Heart Rhythm. 2009;6:1335–1341. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website ( www.brugadadrugs.org). doi: 10.1016/j.hrthm.2009.07.002. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
